There is a vast array of preclinical inflammatory bowel disease (IBD) models, each with their own strengths and limitations. As no one model is ideal for all research uses, it’s important to fully understand the available models, their pros and cons, and which is the most appropriate to use based on a new agent’s target and mechanism of action.
This White Paper presents the five major IBD model categories, with detailed information on specific model types, model development, as well as representative treatment studies.
How to choose the optimal model based on target-dependent mechanisms is also discussed, as well the need to improve IBD model translational relevance to enhance clinical trial outcomes.
Your privacy is important to us.
We'll never share your information.